ANTONIO IGNACIO
FERNÁNDEZ ORTIZ
Profesor asociado de Ciencias de la Salud
Universitat de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (10)
2024
-
Apolipoprotein E-ϵ2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study
Circulation Research, Vol. 134, Núm. 4, pp. 411-424
2023
-
Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial
Revista Espanola de Cardiologia, Vol. 76, Núm. 2, pp. 94-102
-
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2069-2083
-
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study
The Lancet Healthy Longevity, Vol. 4, Núm. 9, pp. e487-e498
2022
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial
European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330
2020
-
Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design
American Heart Journal, Vol. 222, pp. 174-182
2016
-
A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents with Durable Polymer in Patients with Diabetes Mellitus the RESERVOIR Clinical Trial
JACC: Cardiovascular Interventions, Vol. 9, Núm. 1, pp. 42-50
2015
2012
-
Primary percutaneous coronary intervention: Models of intervention in Spain
EuroIntervention, Vol. 8, pp. P90-P93